Inventor · disambiguated record
Stephan D. Parent
Also filed as: PARENT STEPHAN · PARENT STEPHAN D
47 granted patents·29 pending applications·273 citations·filing 2003–2025
98Inventor score
Top patents by PatentIndex Score
76 records- 0198US9447071B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·36 cites·33 claims
- 0297US11725018B2CrystalsAEROMICS INC·Filed 2021·Granted Aug 15, 2023·4 cites·20 claims
- 0397US10137118B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·20 cites·6 claims
- 0496US8088824B2Forms of CDDO methyl esterWALLING JOHN·Filed 2008·Granted Jan 3, 2012·54 cites·16 claims
- 0595US12091431B2CrystalsAEROMICS INC·Filed 2023·Granted Sep 17, 2024·2 cites·18 claims
- 0695US8309601B2Forms of CDDO methyl esterWALLING JOHN·Filed 2011·Granted Nov 13, 2012·40 cites·9 claims
- 0794US11117909B2CrystalsAEROMICS INC·Filed 2017·Granted Sep 14, 2021·6 cites·30 claims
- 0892US8633243B2Forms of CDDO methyl esterWALLING JOHN·Filed 2012·Granted Jan 21, 2014·18 cites·1 claims
- 0992US8063227B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2009·Granted Nov 22, 2011·23 cites·1 claims
- 1089US8227482B1Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2012·Granted Jul 24, 2012·13 cites·23 claims
- 1188US2025032471A1Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1287US11452720B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·1 cites·14 claims
- 1386US11028050B2Salts and polymorphs of a PDE4 inhibitorTETRA DISCOVERY PARTNERS INC·Filed 2020·Granted Jun 8, 2021·3 cites·16 claims
- 1485US9133217B2Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2014·Granted Sep 15, 2015·6 cites·16 claims
- 1585US2025206765A1CrystalsAEROMICS INC·Filed 2024·Application pending·0 cites
- 1684US10722502B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·1 cites·3 claims
- 1784US8735419B2Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2012·Granted May 27, 2014·6 cites·12 claims
- 1884US8507517B2Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2012·Granted Aug 13, 2013·6 cites·12 claims
- 1983US8513275B2Forms of rifaximin and uses thereofWU YIDUO·Filed 2011·Granted Aug 20, 2013·8 cites·6 claims
- 2082US8927761B2Form of hexyl-5-aminolevulinate hydrochloride and methods of using the samePARENT STEPHAN D·Filed 2013·Granted Jan 6, 2015·3 cites·25 claims
- 2182US8815888B2Forms of rifaximin and uses thereofWU YIDUO·Filed 2013·Granted Aug 26, 2014·6 cites·20 claims
- 2282US2022395492A1Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2381US12358873B2Crystalline salts of psilocinCANNA CHEMISTRIES LLC·Filed 2024·Granted Jul 15, 2025·0 cites·19 claims
- 2479US7605270B2Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamateVERTEX PHARMA·Filed 2006·Granted Oct 20, 2009·3 cites·10 claims
- 2576US12473277B2Solid forms of a modulator of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Nov 18, 2025·0 cites·22 claims
- 2675US8003700B2Colchicine solid complex; methods of making; and methods of use thereofMUTUAL PHARAMACEUTICAL COMPANY INC·Filed 2009·Granted Aug 23, 2011·4 cites·7 claims
- 2774US9211290B2Solid dispersions of amorphous paroxetine mesylateNOVEN THERAPEUTICS LLC·Filed 2013·Granted Dec 15, 2015·1 cites·6 claims
- 2872US12017995B2Crystalline forms and salt forms of a kinase inhibitorEXELIXIS INC·Filed 2019·Granted Jun 25, 2024·0 cites·2 claims
- 2972US8846731B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Sep 30, 2014·1 cites·7 claims
- 3071US11851424B2Solid forms of a modulator of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·0 cites·19 claims
- 3171US9585892B2Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewithAMBIT BIOSCIENCES CORP·Filed 2014·Granted Mar 7, 2017·1 cites·20 claims
- 3271US8829197B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Sep 9, 2014·1 cites·3 claims
- 3371US8710087B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Apr 29, 2014·1 cites·6 claims
- 3469US8883783B2Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewithBHAGWAT SHRIPAD S·Filed 2008·Granted Nov 11, 2014·2 cites·23 claims
- 3567US2016346263A1Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3666US9149539B1Crystalline naloxol-PEG conjugateASTRAZENECA AB·Filed 2015·Granted Oct 6, 2015·1 cites·1 claims
- 3766US2024300897A1Crystalline forms and salt forms of a kinase inhibitorEXELIXIS INC·Filed 2024·Application pending·0 cites
- 3865US9012469B2Crystalline naloxol-peg conjugateÅSLUND BENGT LEONARD·Filed 2011·Granted Apr 21, 2015·2 cites·14 claims
- 3964US2024300988A1Crystalline forms of pentaaza macrocyclic ring complexGALERA LABS LLC·Filed 2024·Application pending·0 cites
- 4063US12318370B2Processes for preparing solid state formsVARDA SPACE IND INC·Filed 2024·Granted Jun 3, 2025·0 cites·20 claims
- 4163US2025073244A1Crystalline forms of pentaaza macrocyclic ring complexGALERA LABS LLC·Filed 2024·Application pending·0 cites
- 4263US2025215002A1Solid forms of tyk2 inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 4362US2025388550A1Salts of an antioxidant and crystalline forms thereofTrampota Jan·Filed 2023·Application pending·0 cites
- 4460US2013310409A1Forms of rifaximin and uses thereofPARENT STEPHAN D·Filed 2013·Application pending·0 cites
- 4559US7989632B2Crystalline forms of solvated ilaprazoleIL YANG PHARMACEUTICAL COMPANY LTD·Filed 2007·Granted Aug 2, 2011·0 cites·2 claims
- 4659US2025115622A1Crystalline Forms Of An MCL-1 InhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 4758US8153668B2Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamateBLYTHE TODD·Filed 2009·Granted Apr 10, 2012·0 cites·4 claims
- 4858US7999110B2Solid state forms of racemic ilaprazoleIL YANG PHARMACEUTICAL COMPANY LTD·Filed 2007·Granted Aug 16, 2011·0 cites·3 claims
- 4958US2025122224A1Crystalline Salt and Solvate Forms Of Murizatoclax (AMG 397)AMGEN INC·Filed 2023·Application pending·0 cites
- 5057US8258155B2Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereofSUN TONG·Filed 2009·Granted Sep 4, 2012·0 cites·18 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →